AIZ Insider Notice: 950 Common Shares Proposed Sale via Morgan Stanley

Rhea-AI Filing Summary

Assurant, Inc. submitted a Form 144 disclosing a proposed sale of 950 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $194,707.25. The filing shows 50,702,324 shares outstanding for the issuer and lists an approximate sale date of 08/08/2025.

The securities were acquired as restricted stock vesting under a registered plan: 101 shares on 11/16/2022 and 849 shares on 10/01/2023, with consideration recorded as services rendered. The filer reports no securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Proposed sale is immaterial versus outstanding shares and appears to be routine restricted-stock liquidation.

The Form 144 reports a proposed sale of 950 common shares valued at $194,707.25. Relative to the reported 50,702,324 shares outstanding, the block represents a very small fraction of the outstanding equity, suggesting limited market impact. The filing includes broker information and an approximate sale date of 08/08/2025, which supports market transparency but does not by itself indicate any change in company fundamentals.

Corporate Governance Expert

TL;DR: Disclosure aligns with compliance norms; acquisitions are from restricted-stock vesting and no recent sales were reported.

The notice documents that the shares were acquired via restricted-stock vesting under a registered plan on 11/16/2022 and 10/01/2023 with payment described as services rendered. The form reiterates the filers representation about the absence of undisclosed material adverse information and references trading-plan disclosure requirements, but the provided content does not include a trading-plan adoption date or signature details. Overall, this filing meets routine disclosure expectations for insider transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	950	194707.25	50702324	08/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/16/2022	Restricted stock vesting under a registered plan	Issuer			101	11/16/2022	Services Rendered
Common	10/01/2023	Restricted stock vesting under a registered plan	Issuer			849	10/01/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Assurant (AIZ) shares are proposed for sale in this Form 144?

The Form 144 discloses a proposed sale of 950 common shares.

What is the aggregate market value of the proposed sale of AIZ shares?

The aggregate market value reported is $194,707.25.

Who is the broker handling the proposed sale and where will the sale occur?

The broker listed is Morgan Stanley Smith Barney LLC and the sale is listed on the NYSE.

When were the shares being sold originally acquired?

The filing shows 101 shares acquired on 11/16/2022 and 849 shares acquired on 10/01/2023, both from restricted-stock vesting under a registered plan.

Were any securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

What is the approximate date of the proposed sale?

The approximate date of sale is listed as 08/08/2025.